- Home
- APLT vs PIM Comparison
APLT vs PIM Comparison
Compare APLT & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- PIM
- Stock Information
- Founded
- APLT 2016
- PIM 1988
- Country
- APLT United States
- PIM United States
- Employees
- APLT N/A
- PIM N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- PIM Finance Companies
- Sector
- APLT Health Care
- PIM Finance
- Exchange
- APLT Nasdaq
- PIM Nasdaq
- Market Cap
- APLT 178.6M
- PIM 168.6M
- IPO Year
- APLT 2019
- PIM N/A
- Fundamental
- Price
- APLT $1.05
- PIM $3.42
- Analyst Decision
- APLT Buy
- PIM
- Analyst Count
- APLT 5
- PIM 0
- Target Price
- APLT $4.13
- PIM N/A
- AVG Volume (30 Days)
- APLT 11.8M
- PIM 57.5K
- Earning Date
- APLT 11-06-2025
- PIM 01-01-0001
- Dividend Yield
- APLT N/A
- PIM 8.28%
- EPS Growth
- APLT N/A
- PIM N/A
- EPS
- APLT N/A
- PIM 0.05
- Revenue
- APLT $121,000.00
- PIM N/A
- Revenue This Year
- APLT N/A
- PIM N/A
- Revenue Next Year
- APLT $5,931.24
- PIM N/A
- P/E Ratio
- APLT N/A
- PIM $63.80
- Revenue Growth
- APLT N/A
- PIM N/A
- 52 Week Low
- APLT $0.30
- PIM $2.90
- 52 Week High
- APLT $10.62
- PIM $3.28
- Technical
- Relative Strength Index (RSI)
- APLT 66.45
- PIM N/A
- Support Level
- APLT $0.56
- PIM N/A
- Resistance Level
- APLT $1.32
- PIM N/A
- Average True Range (ATR)
- APLT 0.17
- PIM 0.00
- MACD
- APLT 0.05
- PIM 0.00
- Stochastic Oscillator
- APLT 73.60
- PIM 0.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.